Tex US TOO

Is testosterone always the enemy of prostate cancer patients and survivors?

Join us on Monday night, February 9 at 7PM, as we welcome Dr. Michael Mineo of Houston Metro Urology. He will answer all our questions about the relationship between testosterone and prostate cancer.

Join in person at St. Luke's Methodist Church on Westheimer, or online by Zoom. Information and registration here:

Monthly Meetings – Tex US TOO Support and Education Starts with Making Connections Speaker: Dr. Michael Mineo of Houston Metro Urology and Houston Methodist Hospital Topic: The Relations

Due to some slow updating web software, you may have registered for tonight’s November meeting, but received an automated email that includes a date and Zoom link for the October meeting. If you did, that link will not work. To receive the correct link, please visit our website again and re-register. You should then receive an email with the current link.

https://texustoo.org/monthly-meetings/

We apologize for any inconvenience this may have caused.

Monthly Meetings – Tex US TOO Support and Education Starts with Making Connections Speaker: Dr. Christopher J. Logothetis, Professor of Genitourinary Medical Oncology, The University of Texa

About our May speaker, Dr. Tamara Lotan, MD, Professor at Johns Hopkins University School of Medicine, Baltimore, Maryland

Dr. Lotan is the Rose-Lee and Keith Reinhard Professor of Urologic Pathology and Director of Research for the Brady Urological Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland.

She completed her undergraduate degree at Harvard University (Applied Mathematics), followed by medical school and an Anatomic Pathology Residency at the University of Chicago. After a fellowship in Urology Pathology at Johns Hopkins, she joined the faculty there in 2008 as a physician-scientist focusing on the molecular pathology of genitourinary tumors. Her NIH- and DoD-funded laboratory works on in situ prognostic and predictive molecular biomarkers for prostate cancer using human tissue specimens, developing genetically validated markers that have been transitioned into routine clinical use.

Her group also focuses on the role of ancestry in prostate cancer molecular subtype prevalence. Finally, she co-directs the Schaufeld Program for Prostate Cancer in Black Men, where she leads a post-baccalaureate training program for aspiring physicians.

Please join us for our next monthly meeting on November 14, 7:00 p.m.
See attendance options in the link:
https://texustoo.org/monthly-meetings/

Speaker: Dr. Timothy Thompson
Topic: ” Novel Combination of Therapies for Prostate Cancer”
This is an important topic because treating advanced prostate cancer is not a one size fits all proposition. Prostate Cancer Oncologists are working hard to determine what therapeutic agents and the sequence with which they are administered works best for an individual patient.
Dr. Thompson is a Professor in the Department of Genitourinary Medical Oncology at MD Anderson. He is the Director of Prostate Cancer Basic Science Research and occupies the Joan and Stanford Alexander Distinguished Chair for Prostate Cancer Research. He received his Ph.D. in Pharmaceutical Science from the University of Colorado.

Monthly Meetings – Tex US TOO Support and Education Starts with Making Connections Speaker: Dr. Timothy Thompson Topic: " Novel Combination of Therapies for Prostate Cancer" This is an imp